Codexis to Participate in TD Cowen 44th Annual Health Care Conference

REDWOOD CITY, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will attend the TD Cowen 44th Annual Health Care Conference, being held March 4-6, 2024, in Boston, Massachusetts.

Management will participate in a fireside chat on Monday, March 4, 2024, at 2:50 pm ET. A live webcast of the event will be available here and in the Investor Relations section of the Company’s website, http://ir.codexis.com. A replay will be archived for 90 days following the event.

About Codexis

Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® technology platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis™ manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit https://www.codexis.com.

For More Information

Investor ContactCarrie McKim(336) 608-9706[email protected]

Media ContactLauren Musto(650) 421-8205[email protected]

You May Also Be Interested In

• Aveanna Announces Pricing of Secondary Offering of Common Stock
• Trump’s Crypto Push Fuels BTC Surge While Apeing Emerges as the Best Crypto to Watch in August with Over 12000 Whitelisted Members
• Best Crypto To Buy Now: Hyperliquid Hits Record $106M Fees as Pipedog Rally Sends Meme Hunters Toward AlphaPepe